Target 2035 – an update on private sector contributions
Ackloo S., Antolin AA., Bartolome JM., Beck H., Bullock A., Betz UAK., Böttcher J., Brown PJ., Chaturvedi M., Crisp A., Daniels D., Dreher J., Edfeldt K., Edwards AM., Egner U., Elkins J., Fischer C., Glendorf T., Goldberg S., Hartung IV., Hillisch A., Homan E., Knapp S., Köster M., Krämer O., Llaveria J., Lessel U., Lindemann S., Linderoth L., Matsui H., Michel M., Montel F., Mueller-Fahrnow A., Müller S., Owen DR., Saikatendu KS., Santhakumar V., Sanderson W., Scholten C., Schapira M., Sharma S., Shireman B., Sundström M., Todd MH., Tredup C., Venable J., Willson TM., Arrowsmith CH.
Target 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging ‘open’ principles to develop a pharmacological tool for every human protein.